Why the study?
Does therapy targeting supranormal hemodynamic values using central venous and pulmonary artery catheters reduce mortality and morbidity in critically ill postoperative survivors compared to targeting normal values?
Does therapy targeting supranormal hemodynamic values using central venous and pulmonary artery catheters reduce mortality and morbidity in critically ill postoperative survivors compared to targeting normal values?
Targeting supranormal hemodynamic values using central venous and pulmonary artery catheters significantly reduces morbidity and mortality in critically ill postoperative patients.
Hypothesis-generating for supranormal hemodynamic goals postoperatively; prospective trials needed before clinical adoption.
The purpose of this study was to (1) evaluate the relative cost effectiveness of the central venous pressure and flow-directed pulmonary artery catheters used to maintain normal hemodynamic values as therapeutic goals in the control groups vs supranormal values empirically observed in critically ill postoperative survivors in the protocol groups, and (2) to evaluate tissue perfusion and oxygenation in relationship to organ failure and mortality. In two prospective clinical trials there were no significant differences in outcome between the central venous pressure and pulmonary artery control groups that used normal values as therapeutic goals. However, there were marked and significant reductions in morbidity and mortality of the protocol groups using the supranormal cardiac index, oxygen delivery, and oxygen consumption values as goals. The cumulative oxygen debt was less and organ failures were fewer and less severe in the protocol groups than in the control groups.
No takes yet. Share an insight, caveat, or question.
W. C. Shoemaker (1990) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: